Come up with a name for your new list and we'll add to it:
Bird Rock Bio raised a round of funding on June 11, 2014. Investors include
Silicon Valley Bank.
Bird Rock Bio, formerly RuiYi, is a clinical stage biopharmaceutical company focused on developing immuno-inflammatory regulators. The company's strategy leverages biologic targets with substantial hu…